| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | Chief Development Officer | Common Stock | 291K | $2.9M | $9.98 | 06 Jun 2024 | Direct |
| Rapport Therapeutics, Inc. | Chief Development Officer | Stock Option (Right to Buy) | 110K | 03 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 03 Feb 2025 | 1 | $0 | 4 | Chief Development Officer | 04 Feb 2025, 17:30 |
| RAPP | Rapport Therapeutics, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Chief Development Officer | 10 Jun 2024, 19:42 |
| RAPP | Rapport Therapeutics, Inc. | 06 Jun 2024 | 0 | $0 | 3 | Chief Development Officer | 06 Jun 2024, 18:59 |